Refine Results
  1. "Myeloma"
Formats
  1. Meeting Abstract (286)
  2. Journal Article (284)
  3. Review (15)
  4. Book Section (9)
  5. Research Letter (6)
  6. Correspondence (2)
  7. Guidelines (2)
  8. Conference Paper (1)
  9. Editorial (1)
Groups
  1. Center for Hematologic Malignancies (606)
  2. Myeloma (606)
  3. Hematologic Malignancies Research (418)
  4. Hematologic Malignancies, Division of (382)
  5. Population Sciences Research Program (325)
  6. Hematologic Oncology, Division of (224)

More Groups

People
  1. Carl Landgren (302)
  2. Hani Hassoun (191)
  3. Alexander Lesokhin (152)
  4. Heather Landau (127)
  5. Sham Mailankody (115)
  6. Sergio Giralt (110)

More People

Years
  1. 2021 (21)
  2. 2020 (62)
  3. 2019 (85)
  4. 2018 (81)
  5. 2017 (67)
  6. 2016 (73)

More Years

Publications
  1. Blood (167)
  2. Journal of Clinical Oncology (45)
  3. Haematologica (34)
  4. Biology of Blood and Marrow Transplantation (29)
  5. Clinical Lymphoma, Myeloma and Leukemia (28)
  6. Leukemia and Lymphoma (18)

More Publications

Publishers
  1. American Society of Hematology (179)
  2. Elsevier Inc. (77)
  3. Nature Publishing Group (57)
  4. American Society of Clinical Oncology (47)
  5. Ferrata Storti Foundation (34)
  6. Taylor & Francis Group (26)

More Publishers

Results (606)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Initial whole-genome sequencing of plasma cell neoplasms in first responders and recovery workers exposed to the World Trade Center attack of September 11, 2001
    Journal Article

    Maura, F.; Diamond, B.; Maclachlan, K. H.; Derkach, A.; Yellapantula, V. D.; Rustad, E. H.; Hultcrantz, M.; Shah, U. A.; Hong, J.; Landau, H. J.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Minimal residual disease in multiple myeloma: Defining the role of next generation sequencing and flow cytometry in routine diagnostic use
    Review

    Maclachlan, K. H.; Came, N.; Diamond, B.; Roshal, M.; Ho, C.; Thoren, K.; Mayerhoefer, M. E.; Landgren, O.; Harrison, S.
    Pathology (2021)

    Fulltext@MSK | Save
  • Whole-genome sequencing reveals progressive versus stable myeloma precursor conditions as two distinct entities
    Journal Article

    Oben, B.; Froyen, G.; Maclachlan, K. H.; Leongamornlert, D.; Abascal, F.; Zheng-Lin, B.; Yellapantula, V.; Derkach, A.; Geerdens, E.; Diamond, B. T.; more...
    Nature Communications (2021)

    Fulltext@MSK | Save
  • mmsig: A fitting approach to accurately identify somatic mutational signatures in hematological malignancies
    Journal Article

    Rustad, E. H.; Nadeu, F.; Angelopoulos, N.; Ziccheddu, B.; Bolli, N.; Puente, X. S.; Campo, E.; Landgren, O.; Maura, F.
    Communications Biology (2021)

    Fulltext@MSK | Save
  • A phase 1b study of dual PD-1 and CTLA-4 or KIR blockade in patients with relapsed/refractory lymphoid malignancies
    Journal Article

    Armand, P.; Lesokhin, A.; Borrello, I.; Timmerman, J.; Gutierrez, M.; Zhu, L.; McKiver, M. P.; Ansell, S. M.
    Leukemia (2021)

    Fulltext@MSK | Save
  • Defining the undetectable: The current landscape of minimal residual disease assessment in multiple myeloma and goals for future clarity
    Review

    Diamond, B. T.; Rustad, E.; Maclachlan, K.; Thoren, K.; Ho, C.; Roshal, M.; Ulaner, G. A.; Landgren, C. O.
    Blood Reviews (2021)

    Fulltext@MSK | Save
  • Oncologic immunomodulatory agents in patients with cancer and COVID-19
    Journal Article

    Jee, J.; Stonestrom, A. J.; Devlin, S.; Nguyentran, T.; Wills, B.; Narendra, V.; Foote, M. B.; Lumish, M.; Vardhana, S. A.; Pastores, S. M.; more...
    Scientific Reports (2021)

    Fulltext@MSK | Save
  • Melflufen and dexamethasone in heavily pretreated relapsed and refractory multiple myeloma
    Journal Article

    Richardson, P. G.; Oriol, A.; Larocca, A.; Bladé, J.; Cavo, M.; Rodriguez-Otero, P.; Leleu, X.; Nadeem, O.; Hiemenz, J. W.; Hassoun, H.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Assessment of outcomes associated with the use of newly approved oncology drugs in medicare beneficiaries
    Journal Article

    Green, A. K.; Curry, M.; Trivedi, N.; Bach, P. B.; Mailankody, S.
    JAMA Network Open (2021)

    Fulltext@MSK | Save
  • Fecal microbiota diversity disruption and clinical outcomes after auto-HCT: A multicenter observational study
    Journal Article

    Khan, N.; Lindner, S.; Gomes, A. L. C.; Devlin, S. M.; Shah, G. L.; Sung, A. D.; Sauter, C. S.; Landau, H. J.; Dahi, P. B.; Perales, M. A.; more...
    Blood (2021)

    Fulltext@MSK | Save